A18.03 Tuberculosis of other bones

Name of the Condition

• Tuberculosis of other bones
• ICD Code: A18.03

Summary

Tuberculosis of other bones is a form of extrapulmonary tuberculosis where Mycobacterium tuberculosis infects bones outside the spine or major weight-bearing joints. This condition typically results from the spread of TB bacteria from a primary site, most commonly the lungs, via the bloodstream or lymphatic system. It can affect various non-vertebral, non-weight-bearing bones, such as the ribs, skull, or small long bones, and may present with localized symptoms depending on the site of infection.

Causes

Tuberculosis of other bones is caused by the dissemination of Mycobacterium tuberculosis from an existing infection, usually pulmonary tuberculosis. The bacteria may travel to non-vertebral bones during active disease or reactivation of latent TB. Direct inoculation is rare but possible in certain cases.

Risk Factors

• Immunocompromised states, such as HIV/AIDS or chronic immunosuppressive therapy.
• History of untreated or inadequately treated tuberculosis.
• Close contact with individuals who have active TB.
• Living in or traveling to regions with high TB prevalence.
• Underlying conditions like diabetes, malnutrition, or chronic kidney disease.

Symptoms

• Persistent localized pain, often worsening at night or with movement.
• Stiffness or reduced range of motion in affected areas.
• Swelling or warmth around the affected bone.
• Possible deformity or pathological fracture in advanced cases.

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies (e.g., X-rays, MRI, or CT scans), and laboratory tests. Imaging may reveal bone lesions, abscesses, or destructive changes. Laboratory tests include acid-fast bacilli (AFB) smears, cultures, or nucleic acid amplification tests (NAATs) from tissue samples or fluid aspirates. Biopsy of the affected bone may be performed to confirm the presence of Mycobacterium tuberculosis and rule out other conditions.

Treatment Options

Treatment typically follows standard multidrug antitubercular therapy (MDT) regimens, including isoniazid, rifampin, pyrazinamide, and ethambutol, administered for an extended period (usually 6–12 months). Surgical intervention may be necessary for abscess drainage, debridement, or stabilization of affected bones. Pain management and physical therapy are often adjunctive measures.

Prognosis and Follow-Up

Prognosis depends on early diagnosis, adherence to treatment, and the extent of bone damage. With appropriate therapy, most patients achieve resolution of infection, though residual deformity or functional impairment may occur. Follow-up includes monitoring for treatment response, potential relapse, and complications, with regular clinical and imaging assessments.

Complications

• Chronic bone pain or deformity.
• Pathological fractures.
• Spread of infection to adjacent tissues or joints.
• Neurological complications if nearby structures are involved.
• Treatment-related adverse effects (e.g., hepatotoxicity from antitubercular drugs).

Lifestyle & Prevention

• Complete the full course of prescribed antitubercular therapy to prevent relapse.
• Maintain good nutrition and overall health to support immune function.
• Avoid close contact with individuals who have active TB until they are no longer infectious.
• Follow public health guidelines for TB prevention, including vaccination (BCG) where recommended.

When to Seek Professional Help

Seek medical attention if you experience persistent bone pain, unexplained swelling, fever, or signs of infection. Prompt evaluation is critical to prevent progression and complications, especially in immunocompromised individuals or those with a history of TB exposure.

Tips for Medical Coders

Code A18.03 is assigned for tuberculosis of bones other than the spine or major weight-bearing joints. Documentation should specify the affected bone(s) and confirm the diagnosis through clinical, imaging, or laboratory findings. Ensure the code is not used for spinal or major joint involvement, which have separate codes. Verify that the condition is extrapulmonary and not a reactivation of latent TB without active disease.